Preclinical Characterization of Pharmacologic NAD+ Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritis

RAFAELA ORTEGA CASTROALEJANDRO ESCUDERO CONTRERASALEJANDRO ESCUDERO CONTRERASEDUARDO COLLANTES ESTÉVEZMª ISABEL BURON ROMEROJUAN ANTONIO MORENO GUTIERREZJOSE ANTONIO GONZALEZ REYESJOSE MANUEL VILLALBA MONTOROCARLOS PÉREZ SÁNCHEZ2026-01-292026-01-29202310.1002/art.425282-s2.0-85164674404https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/36618ImmunologyImmunology and AllergyRheumatologyPreclinical Characterization of Pharmacologic NAD+ Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritisresearch article